Targeting the SAGA and ATAC Transcriptional Coactivator Complexes in MYC-Driven Cancers
©2020 American Association for Cancer Research..
Targeting epigenetic regulators, such as histone-modifying enzymes, provides novel strategies for cancer therapy. The GCN5 lysine acetyltransferase (KAT) functions together with MYC both during normal development and in oncogenesis. As transcription factors, MYC family members are difficult to target with small-molecule inhibitors, but the acetyltransferase domain and the bromodomain in GCN5 might provide alternative targets for disruption of MYC-driven functions. GCN5 is part of two distinct multiprotein histone-modifying complexes, SAGA and ATAC. This review summarizes key findings on the roles of SAGA and ATAC in embryo development and in cancer to better understand the functional relationships of these complexes with MYC family members, as well as their future potential as therapeutic targets.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:80 |
---|---|
Enthalten in: |
Cancer research - 80(2020), 10 vom: 15. Mai, Seite 1905-1911 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Mustachio, Lisa Maria [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 26.10.2020 Date Revised 15.11.2020 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1158/0008-5472.CAN-19-3652 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM306869004 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM306869004 | ||
003 | DE-627 | ||
005 | 20231225124323.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1158/0008-5472.CAN-19-3652 |2 doi | |
028 | 5 | 2 | |a pubmed24n1022.xml |
035 | |a (DE-627)NLM306869004 | ||
035 | |a (NLM)32094302 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Mustachio, Lisa Maria |e verfasserin |4 aut | |
245 | 1 | 0 | |a Targeting the SAGA and ATAC Transcriptional Coactivator Complexes in MYC-Driven Cancers |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 26.10.2020 | ||
500 | |a Date Revised 15.11.2020 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a ©2020 American Association for Cancer Research. | ||
520 | |a Targeting epigenetic regulators, such as histone-modifying enzymes, provides novel strategies for cancer therapy. The GCN5 lysine acetyltransferase (KAT) functions together with MYC both during normal development and in oncogenesis. As transcription factors, MYC family members are difficult to target with small-molecule inhibitors, but the acetyltransferase domain and the bromodomain in GCN5 might provide alternative targets for disruption of MYC-driven functions. GCN5 is part of two distinct multiprotein histone-modifying complexes, SAGA and ATAC. This review summarizes key findings on the roles of SAGA and ATAC in embryo development and in cancer to better understand the functional relationships of these complexes with MYC family members, as well as their future potential as therapeutic targets | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, N.I.H., Extramural | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Review | |
650 | 7 | |a Proto-Oncogene Proteins c-myc |2 NLM | |
650 | 7 | |a Transcription Factors |2 NLM | |
650 | 7 | |a p300-CBP Transcription Factors |2 NLM | |
650 | 7 | |a EC 2.3.1.48 |2 NLM | |
650 | 7 | |a p300-CBP-associated factor |2 NLM | |
650 | 7 | |a EC 2.3.1.48 |2 NLM | |
700 | 1 | |a Roszik, Jason |e verfasserin |4 aut | |
700 | 1 | |a Farria, Aimee |e verfasserin |4 aut | |
700 | 1 | |a Dent, Sharon Y R |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Cancer research |d 1945 |g 80(2020), 10 vom: 15. Mai, Seite 1905-1911 |w (DE-627)NLM000001740 |x 1538-7445 |7 nnns |
773 | 1 | 8 | |g volume:80 |g year:2020 |g number:10 |g day:15 |g month:05 |g pages:1905-1911 |
856 | 4 | 0 | |u http://dx.doi.org/10.1158/0008-5472.CAN-19-3652 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 80 |j 2020 |e 10 |b 15 |c 05 |h 1905-1911 |